Peter Staller
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Chemokine receptors and signaling
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 7
- Cancer-related Molecular Pathways 4
- Chemokine receptors and signaling 2
-
- Cancer, Hypoxia, and Metabolism 1
- Protease and Inhibitor Mechanisms 1
- Co-authors
- Martin Eilers (5 shared papers)Holger Moch (2 shared papers)Wilhelm Krek (2 shared papers)Edward J. Oakeley (1 shared paper)Joanna Hergovich Lisztwan (1 shared paper)Joan Seoane (2 shared papers)Joan Massagué (2 shared papers)Caroline Bouchard (2 shared papers)
- Journals
- Oncogene (3 papers)Nature Cell Biology (2 papers)The Journal of Pathology (1 paper)The EMBO Journal (1 paper)Trends in Cell Biology (1 paper)
- Partner nations
- GermanyDenmarkUnited States
In The Last Decade
Peter Staller
14 papers receiving 2.6k citations
Peter Staller's Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 807
- Cancer Research 419
- Molecular Biology 1.2k
- Pulmonary and Respiratory Medicine 276
- Genetics 66
Countries citing papers authored by Peter Staller
This map shows the geographic impact of Peter Staller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Staller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Staller more than expected).
Fields of papers citing papers by Peter Staller
This network shows the impact of papers produced by Peter Staller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Staller. The network helps show where Peter Staller may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Staller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL Hit paper breakdown → | 2003 | 754 |
| 2 | 2001 | 469 | |
| 3 | 2001 | 409 | |
| 4 | 2008 | 296 | |
| 5 | 1998 | 213 | |
| 6 | 2013 | 111 | |
| 7 | 2011 | 107 | |
| 8 | 1999 | 104 | |
| 9 | 2014 | 95 | |
| 10 | 2008 | 66 | |
| 11 | 1997 | 65 | |
| 12 | 2018 | 27 | |
| 13 | 2010 | 6 | |
| 14 | 2015 | 1 |
About Peter Staller
Peter Staller is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Nuclear Energy and Engineering, having authored 14 papers that have together received 2.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Cancer-related Molecular Pathways (4 papers), Chemokine receptors and signaling (2 papers), Renal cell carcinoma treatment (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Protease and Inhibitor Mechanisms (1 paper), TGF-β signaling in diseases (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Oncology (807 citations), Cancer Research (419 citations), Molecular Biology (1.2k citations), Pulmonary and Respiratory Medicine (276 citations) and Genetics (66 citations). Peter Staller has collaborated with scholars based in Germany, Denmark and United States. Frequent co-authors include Martin Eilers, Holger Moch, Wilhelm Krek, Edward J. Oakeley, Joanna Hergovich Lisztwan, Joan Seoane, Joan Massagué, Caroline Bouchard, Célio Pouponnot and Kim Steen Jensen. Their work appears in journals such as Oncogene, Nature Cell Biology, The Journal of Pathology, The EMBO Journal and Trends in Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.